Jump to Navigation
Trends and Sentiments
Comments and Analysis
Clean up crews to go into Mississippi River after oil...
What will Apple announce on Wednesday?
This city has America's highest minimum wage
The Tell: Money flows back to stock funds as investors...
‘He wants to stay…next to them’: Alan Kurdi’s father...
Capitol Report: Donald Trump stumbles during interview on...
Currencies: Dollar weakens ahead of August jobs report
Johnny Depp wows Venice in gritty gangster tale '...
RBS scheme slashes hedge funds as outperformance rolls on
This Is Not A Retest - It's A Live Bear
Antares Pharma's New Blockbuster Drug Has Potential To Generate Long-Term Revenue
Antares Pharma: Insiders And Institutions Appear Bullish
These 2 Bio-Pharmas Could Be High Flyers In 2012
WebMD Hammered On Latest News
Ariad: This Bio-Pharma May Deliver Big Returns
Seadrill Limited: $3 A Share Dividend
SIGA Could Be Ready For A Large Short-Term Pop
Questcor: A Mid Cap Bio-Pharma With Bullish Indicators
Molycorp: Don't Buy Into The Hype
A Bio-Pharma Buy And Sell List: Part 2
A Bio-Pharma Buy And Sell List: Part 1
These Stocks Might Be Good Swing Trades
Stock Boards: Weeding Through The Nonsense, Getting To The Facts
Spectrum Pharma: Solid Tech, Solid Fundamentals, Explosive Growth
Vertex Pharmaceuticals Could See Huge Long-Term Gains
Movers And Shakers In This Week's Market
Antares's New RA Treatment Method Has Large Market Potential
GlaxoSmithKline Poised To Break 52-Week High
The Curious Case Of MannKind Corporation
Vertex Pharma's Latest FDA Approval Is Only The Beginning
Easing The Pain: Why Investment In Bio-Pharma Is A Worthy Cause
The Birth Control Pill Fiasco: Will It Be Bad For Pfizer?
BioLineRx: Strong Speculation Bio-Pharma, Strong Acquisition Target
Short Term Swing Trades 2 Week Report Card, With Deeper Analysis
Soyuz with Russian, Dane, Kazakh docks at space...
Crowd erupts in chants of ‘Harper!’ as Wildrose...
EUR/GBP: 1.3725 USD/EUR: 1.1097 JPY/USD: 119.5450
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions